+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act



Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act



Medical Care 55(1): 43-49



The Affordable Care Act (ACA) include provisions that reduce beneficiaries' cost sharing and eventually closes the coverage gap-known as the "doughnut hole"-that was originally part of Medicare prescription drug coverage implemented in 2006. This study examines changes in overall prescription drug utilization and out-of-pocket spending as well as by manufacturer type (brand vs. generic), through 2013 as a result of the doughnut hole provisions of the ACA. This analysis is based on data from Medical Expenditure Panel Survey and the sample for this analysis includes all individuals 55 years of age and older. A difference-in-differences methodology was adopted to measure changes in drug utilization and out-of-pocket spending among both the treatment group and the comparison group after the ACA. The findings from this study suggest that overall out-of-pocket spending significantly decreased after closing the coverage gap, mainly because of a significant reduction in out-of-pocket spending on brand-name drugs. Conversely, the results show that generic drug utilization increased after closing the coverage gap. As expected, the effects were considerably larger for people who fell into the doughnut hole. The ACA doughnut hole provisions likely contributed to a reduction in out-of-pocket spending for prescription drugs for part D beneficiaries, especially for people who fell into the doughnut hole.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057430660

Download citation: RISBibTeXText

PMID: 27547949

DOI: 10.1097/mlr.0000000000000613


Related references

Prescription drug coverage, utilization, and spending among Medicare beneficiaries. Health Affairs 18(1): 231-243, 1999

Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans. Journal of the American Society of Nephrology 17(9): 2546-2553, 2006

The effect of supplemental medical and prescription drug coverage on health care spending for Medicare beneficiaries with cancer. Value in Health 17(1): 15-21, 2014

Prescription drug coverage and spending for Medicare beneficiaries. Health Care Financing Review 20(3): 15-27, 1999

Medicare prescription drug coverage gap: navigating the "doughnut hole" with patients. JAMA 297(8): 868-870, 2007

National trends in out-of-pocket prescription drug spending among elderly medicare beneficiaries. Expert Review of Pharmacoeconomics and Outcomes Research 5(3): 297-315, 2005

Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending. Health Services Research 40(5 Pt 1): 1279-1296, 2005

Drug coverage, utilization, and spending by Medicare beneficiaries with heart disease. Health Care Financing Review 24(3): 139-156, 2003

Medicare Part D: decision, decisions, decisions. Medicare prescription drug coverage should save many people some money, but it puts a new burden on beneficiaries to be smart shoppers. Harvard Health Letter 31(2): 4-5, 2006

How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences 65(4): 502-507, 2010

Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures. Health Services Research 45(1): 133-151, 2010

Effect of prescription drug coverage on the cost of care to Medicare beneficiaries with asthma. Expert Review of Pharmacoeconomics and Outcomes Research 4(4): 421-428, 2004

Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending. JAMA Internal Medicine 177(8): 1185-1188, 2017

Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D. JAMA Ophthalmology 134(2): 212-220, 2016

Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Services Research 45(2): 355-375, 2010